Clinical trial · Interventional
Effectiveness of a Nutritional Consultation and Exercise Program in Esophageal Cancer Patient
The Effectiveness of a Nutritional Consultation and Exercise Program in Esophageal Cancer Patient Receiving Neoadjuvant Chemoradiation.
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
In this randomized pilot study, a nutritional consultation combining exercise program is planned for 25 locally advanced esophageal cancer patients undergoing neoadjuvant chemoradiation. The purpose of this study is to determine the effects of nutritional and exercise intervention in locally advanced esophageal cancer patients undergoing neoadjuvant chemoradiation.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Esophageal Cancer | Malignant Esophageal Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| nutritional consultation and exercise program | Behavioral | — | UNRESOLVED |
| usual care | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- nutrition consultation and exercise program
- description
- individual nutritional consultation and exercise
- interventionNames
- Behavioral: nutritional consultation and exercise program
- type
- ACTIVE_COMPARATOR
- label
- usual care
- description
- pre-CCRT education included self-care during CCRT and body weight maintenance
- interventionNames
- Behavioral: usual care
Primary outcomes (1)
- measure
- General nutritional status
- timeFrame
- 10 weeks
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 20 Years
- Maximum age
- 90 Years
Show eligibility criteria text
Inclusion Criteria: * Clinical diagnosis of locally advanced esophageal cancer, neoadjuvant chemoradiation is indicated * Informed consent signed Exclusion Criteria: * stage IV, underwent palliative chemotherapy or radiotherapy patient * clinically significant cardiac or pulmonary disease * Unable to walk or exercise
References
Publications (0)
Data not yet available